Key publications

25th March 2021/by IPOPI

SAFE Task Force releases two position statements

Two papers aimed for NMO representatives use in their advocacy work on access to immunoglobulin replacement therapies

20th January 2021/by IPOPI

Latest news on COVID-19 and PID

12th January 2021/by IPOPI

COVID-19 Learning Expedition Report released

IPOPI launched the COVID-19 Learning Expedition (LEX) in July 2020, to identify, analyse and provide recommendations on issues brought about by the COVID-19 pandemic for patients with primary immunodeficiency (PID).

3rd November 2020/by IPOPI

IPOPI’s 2019 Review of Activities and Achievements

29th May 2020/by IPOPI

IPOPI publishes the 3rd update to the Joint Statement on COVID-19

12th May 2020/by IPOPI

IPIC2019 – Congress report

9th April 2020/by IPOPI

IPOPI publishes an updated Joint Statement on COVID-19

26th March 2020/by IPOPI

IPOPI calls on authorities to ensure appropriate supply of immunoglobulins

19th March 2020/by IPOPI

Latest news on COVID-19 and PID

11th March 2020/by IPOPI

IPOPI publishes a Joint Statement on the epidemics of COVID-19

11th February 2020/by IPOPI

IPOPI publishes statement on the current epidemics of new Coronavirus

26th September 2019/by IPOPI

IPOPI’s 2018 Review of Activities and Achievements

10th July 2019/by IPOPI

PIDs included in WHO List of Essential Diagnostic Tests

19th June 2019/by IPOPI

Haematopoietic stem cell transplantation

31st May 2019/by IPOPI

European Medicines Agency renews IPOPI’s mandate

13th May 2019/by IPOPI

IPOPI Regional African Patients Meeting report published

4th February 2019/by IPOPI

PLUS Consensus principles on strategies to encourage donations

26th October 2018/by IPOPI

Safety and Efficacy of Immunoglobulin: A Guide for Users, Assessors and Funders

16th July 2018/by IPOPI

Being the parent of a teenager with a chronic illness by Dr Lotte Denning

6th July 2018/by IPOPI

What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic Review

18th May 2018/by IPOPI

IPIC2017 – Congress report

8th March 2018/by IPOPI

IPOPI publishes Position Statement on Access to Immunoglobulin Therapies

13th December 2017/by IPOPI

Asia Pacific Economic Cooperation 2017 publications

29th August 2016/by IPOPI

PID Principles of Care Implementation Package

9th April 2015/by IPOPI

Publication of PIDs Principles of Care

13th May 2014/by IPOPI

IPOPI Patient Needs and Outlooks Study Publication

5th July 2013/by IPOPI

IPIC2013 Report of Highlights

4th July 2013/by IPOPI

PLUS Open Letter to ABO Risk-Based Decision Making

3rd July 2013/by IPOPI

The Dublin Consensus Statement 2012 on optimised supply of plasma-derived medicinal products

6th December 2012/by IPOPI

IPOPI PID Patient Needs & Outlooks Survey

7th December 2011/by IPOPI

Health Technology Assessments (HTAs) and Rare Diseases Therapies

6th December 2011/by IPOPI

Focus on Immunodeficiencies

5th December 2011/by IPOPI

IPOPI First NMO Survey

16th July 2011/by IPOPI

PLUS – The Dublin Consensus Statement Vox 2011

18th March 2011/by IPOPI

The Story of Primary Immunodeficiencies “Despite the challenges, the story is not one of despair”

17th March 2011/by IPOPI

Living With Primary Immunodeficiencies

13th March 2011/by IPOPI

List of Some Primary Immunodeficiencies

12th March 2011/by IPOPI

Report of the scientific sessions of the XIVth Meeting of the European Society for Primary Immunodeficiencies

5th March 2011/by IPOPI

PID Glossary

16th February 2010/by IPOPI

PLUS – The Dublin Consensus Statement on vital issues relating to the collection of blood and plasma and the manufacture of plasma products